A case of listerial meningitis treated with a regimen containing panipenem-betamipron

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Shigemi HitomiAkira Matsui

Abstract

Although panipenem-betamipron, which is commercially available only in Japan, is recommended for treatment of pediatric bacterial meningitis by some experts, only a limited number of clinical studies have been reported. In the present report, we describe a 2-year-old boy with meningitis caused by Listeria monocytogenes who was treated with a regimen containing panipenem-betamipron and recovered without any apparent neurological sequelae. On the basis of our experience and previous reports, panipenem-betamipron appears to be effective for the treatment of listerial meningitis.

References

Nov 1, 1991·Reviews of Infectious Diseases·C E CherubinC W Stratton
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·K NairnJ R Edwards
Jan 5, 2002·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·K SunakawaK Hasegawa

❮ Previous
Next ❯

Citations

Jan 30, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Sadaya MatanoTatsuho Sugimoto
Apr 8, 2016·Pediatric Emergency Care·Giovanna VillaSalvatore Renna
Dec 31, 2018·Italian Journal of Pediatrics·Massimo Luca CastellazziSamantha Bosis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.